Literature DB >> 26620726

MicroRNAs: Modulators of the Ras Oncogenes in Oral Cancer.

Avaniyapuram Kannan Murugan1, Arasambattu Kannan Munirajan2, Ali S Alzahrani1.   

Abstract

Oral squamous cell carcinoma (OSCC) of the head and neck is one of the six most common cancers in the world. OSCC remains the most common cause of cancer deaths in Asian countries. Conventional treatments for OSCC have not improved the overall 5 years survival and therefore alternative therapeutic targets are often sought. Ras is one of the most frequently deregulated oncogenes in oral cancer. Direct targeting the ras has proven unrealistic and hence, exploring and understanding alternative pathways and/or molecules which regulate ras and its signaling that could pave the way for novel molecular targets and therapy for oral cancer. Recently, microRNAs (miRNAs) have been reported to regulate ras oncogenes in human cancers. In this article, we address the microRNA-mediated regulation of the ras oncogenes in oral cancer. We describe extensively the tumor suppressive and oncogenic roles of miRNAs in regulation of ras oncogenes in OSCC. We also discuss the role of miRNA-mediated ras regulation in therapeutic determination of oral cancer. Complete understanding of the miRNA regulation of ras oncogenes in oral cancer may facilitate to plan better strategies for diagnosis, molecular therapeutic targeting and the overall prognosis of this common and deadly cancer.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26620726     DOI: 10.1002/jcp.25269

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

Review 1.  MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.

Authors:  Min Cao; Lijuan Zheng; Jianzhou Liu; Thomas Dobleman; Shen Hu; Vay Liang W Go; Ge Gao; Gary Guishan Xiao
Journal:  Clin Oral Investig       Date:  2018-01-03       Impact factor: 3.573

2.  MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma.

Authors:  Yuan Zhao; Zhiqiang Ling; Yubin Hao; Xiaowu Pang; Xianlin Han; Joseph A Califano; Liang Shan; Xinbin Gu
Journal:  Oncotarget       Date:  2017-04-11

Review 3.  Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.

Authors:  Wang Gong; Yandi Xiao; Zihao Wei; Yao Yuan; Min Qiu; Chongkui Sun; Xin Zeng; Xinhua Liang; Mingye Feng; Qianming Chen
Journal:  Oncotarget       Date:  2017-01-10

4.  MicroRNA-transcription factor network analysis reveals miRNAs cooperatively suppress RORA in oral squamous cell carcinoma.

Authors:  Xueqing Zheng; Kejing Wu; Shengjie Liao; Yuemei Pan; Yanan Sun; Xinming Chen; Yi Zhang; Shu Xia; Yaying Hu; Jiali Zhang
Journal:  Oncogenesis       Date:  2018-10-08       Impact factor: 7.485

5.  Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma.

Authors:  An Song; Yuanyuan Wu; Weiming Chu; Xueming Yang; Zaiou Zhu; Enshi Yan; Wei Zhang; Junbo Zhou; Xu Ding; Jie Liu; Hongxia Zhu; Jinhai Ye; Yunong Wu; Yang Zheng; Xiaomeng Song
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.